NPI: 1528301900 · KANSAS CITY, KS 66112 · General Acute Care Hospital · NPI assigned 04/03/2013
Authorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
| Authorized Official | DOAN, CHRISTOPHER (MANAGING ASSOCIATE GENERAL COUNSEL) |
| NPI Enumeration Date | 04/03/2013 |
Other providers sharing the same authorized official: DOAN, CHRISTOPHER
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,592 | $524K |
| 2019 | 14,692 | $330K |
| 2020 | 9,618 | $182K |
| 2021 | 8,027 | $147K |
| 2022 | 13,917 | $278K |
| 2023 | 23,920 | $421K |
| 2024 | 10,623 | $255K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 12,388 | 11,476 | $582K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 9,495 | 8,567 | $475K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7,444 | 6,494 | $371K |
| 87428 | 1,998 | 1,810 | $75K | |
| 80053 | Comprehensive metabolic panel | 7,258 | 6,137 | $75K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,703 | 2,270 | $59K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9,934 | 8,415 | $54K |
| 81001 | 7,116 | 6,326 | $41K | |
| 81025 | 3,326 | 2,903 | $34K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,457 | 2,013 | $31K |
| 71045 | Radiologic examination, chest; single view | 2,124 | 1,828 | $31K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,754 | 849 | $30K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 334 | 137 | $30K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 415 | 377 | $24K |
| 96375 | Therapeutic injection; each additional sequential IV push | 978 | 802 | $24K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,039 | 872 | $20K |
| 70450 | Computed tomography, head or brain; without contrast material | 268 | 241 | $19K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,836 | 1,612 | $16K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 137 | 122 | $11K |
| 84484 | 1,733 | 1,177 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 747 | 589 | $10K |
| 83690 | 1,839 | 1,566 | $9K | |
| G0378 | Hospital observation service, per hour | 383 | 261 | $9K |
| 36415 | Collection of venous blood by venipuncture | 10,355 | 8,713 | $8K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 204 | 64 | $7K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 137 | 128 | $7K |
| 71046 | Radiologic examination, chest; 2 views | 318 | 304 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | 694 | 598 | $6K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 96 | 95 | $4K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 124 | 119 | $4K |
| 62323 | 27 | 24 | $3K | |
| 83735 | 439 | 381 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 64 | 64 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 64 | 64 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 298 | 292 | $3K |
| 85610 | 525 | 434 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 56 | 54 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 48 | 42 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 74 | 71 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 36 | 32 | $2K |
| 80076 | 70 | 67 | $2K | |
| 87070 | 191 | 190 | $2K | |
| 76801 | 30 | 28 | $2K | |
| 83880 | 127 | 112 | $2K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 28 | 28 | $2K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 93 | 29 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 27 | 25 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 88 | 86 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 131 | 107 | $1K |
| 85730 | 365 | 297 | $1K | |
| 97597 | 19 | 12 | $994.49 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 12 | 12 | $986.07 |
| 97162 | 16 | 16 | $766.98 | |
| 82553 | 57 | 51 | $714.44 | |
| 87420 | 55 | 55 | $663.91 | |
| 73610 | 26 | 25 | $514.75 | |
| 87807 | 34 | 33 | $497.72 | |
| 87186 | 37 | 34 | $456.30 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 29 | 27 | $427.17 |
| 81003 | 415 | 369 | $415.02 | |
| 73630 | 18 | 17 | $414.53 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 275 | 216 | $406.08 |
| G0379 | Direct admission of patient for hospital observation care | 313 | 242 | $391.23 |
| 87077 | 42 | 39 | $360.32 | |
| 96376 | 28 | 26 | $355.50 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 544 | 436 | $292.27 |
| 84702 | 26 | 25 | $274.90 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 72 | 66 | $274.71 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 455 | 339 | $256.03 |
| 87081 | 36 | 33 | $224.86 | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 40 | 40 | $197.78 |
| 84443 | Thyroid stimulating hormone (TSH) | 17 | 17 | $181.13 |
| 83605 | 35 | 24 | $171.82 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 218 | 165 | $168.74 |
| 82962 | 47 | 29 | $163.87 | |
| 85379 | 16 | 14 | $142.95 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 214 | 97 | $128.91 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 26 | 25 | $100.02 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 414 | 365 | $97.41 |
| 86901 | 14 | 12 | $73.40 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,988 | 1,689 | $62.08 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 89 | 64 | $47.34 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 138 | 114 | $45.46 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 28 | 25 | $35.16 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 60 | 47 | $27.12 |
| J8540 | Dexamethasone, oral, 0.25 mg | 140 | 125 | $8.57 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 26 | 25 | $5.99 |
| 85007 | 33 | 33 | $5.28 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 16 | 15 | $2.44 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 426 | 236 | $1.91 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 29 | 14 | $1.25 |
| J2704 | Injection, propofol, 10 mg | 149 | 116 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 289 | 252 | $0.00 |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 13 | 13 | $0.00 |